221006-66-2

Basic information

• Product Name: 3-PHENOXYBENZENEBORONIC ACID
• Synonyms: 3-PHENOXYPHNEYLBORONIC ACID;3-PHENOXYBENZENEBORONIC ACID;3-Phenoxyphenylboronic acid;3-Phenoxybenzeneboronic acid, 97+%;B-(3-phenoxy-phenyl)boronic acid;(3-Phenoxyphenyl)
• CAS NO: 221006-66-2
• Molecular Formula: C₁₂H₁₁BO₃
• Molecular Weight: 214.02
• Mol File: 221006-66-2.mol
• Article Data: 5

Chemical Properties

• Melting Point: 138-143℃
• Boiling Point: 391.1±44.0 °C(Predicted)
• Appearance: /
• Density: 1.23±0.1 g/cm3(Predicted)
• Storage Temp.: Room temperature.
• Solubility: Slightly soluble.
• PKA: 7.82±0.10(Predicted)
• CAS DataBase Reference: 3-PHENOXYBENZENEBORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-PHENOXYBENZENEBORONIC ACID(221006-66-2)
• EPA Substance Registry System: 3-PHENOXYBENZENEBORONIC ACID(221006-66-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 221006-66-2(Hazardous Substances Data)

Usage

Description

3-Phenoxybenzeneboronic acid is an organic compound that is formed as a result of the extensive use of products containing polybrominated diphenyl ethers (PBDEs). It is characterized by the presence of a phenoxy group attached to a benzene ring and a boronic acid functional group.

Uses

Used in Environmental Applications:
3-Phenoxybenzeneboronic acid is used as a chemical intermediate in the production of various compounds and materials. It is also used in the development of new methods for the detection and removal of pollutants, such as PBDEs, from the environment.
Used in Chemical Research:
3-Phenoxybenzeneboronic acid is used as a research compound in the field of organic chemistry. It is utilized in the synthesis of various organic compounds and the study of their properties and applications.
Used in Pharmaceutical Industry:
3-Phenoxybenzeneboronic acid is used as a building block in the development of new pharmaceutical compounds. Its unique structure and functional groups make it a valuable component in the design of novel drugs with potential therapeutic applications.
Used in Material Science:
3-Phenoxybenzeneboronic acid is used in the development of new materials with specific properties, such as high thermal stability, electrical conductivity, or optical properties. It can be incorporated into polymers, coatings, and other materials to enhance their performance and functionality.

Upstream product

• 6876-00-2 3-bromodiphenyl ether 

Downstream Products

• 26076-68-6 2-(3-phenoxy-phenyl)-[1,3,6,2]dioxazaborocane 
• 576169-45-4 ethyl 3-(3-phenoxyphenyl)-2-furancarboxylate 
• 1015760-74-3 1-(8-(3-phenoxyphenyl)-3,4-dihydroquinolin-1(2H)-yl)ethanone 
• 115809-97-7 methyl (3-phenoxyphenyl)carbamate 
• 1266161-17-4 3-chloro-5-(4-phenoxyphenyl)isonicotinonilrile 
• 1266161-26-5 2,3-dichloro-5-(4-phenoxyphenyl)isonicotinonitrile 
• 713-68-8 meta-phenoxyphenol 

Relevant articles and documents

Anthracene compound, preparing method of anthracene compound and organic light-emitting device

The invention provides an anthracene compound. The anthracene compound has a structure in the formula (I), wherein Q is the C1-60 alkyl group or the C6-60 aryl group or the C5-60 condensed ring group or the C5-60 heterocyclic group; Ar is the C6-60 aryl group or the C5-60 condensed ring group or the C5-60 heterocyclic group; and Ar1 is H, the C1-60 alkyl group, the C1-60 alkoxy group, the C1-60 ether group, the C6-60 aryl group, the C6-60 condensed ring group, the C6-60 heterocyclic group and the C6-60 arylamine group. Compared with the prior art, the anthracene compound is connected with an aromatic compound through anthracene, and the Q, Ar and Ar1 groups are introduced, so that a device emits blue light after the organic compound is applied to the organic light-emitting device; and meanwhile, the means that the above groups are used for adjusting the light-emitting wavelength is adopted, the light-emitting efficiency of the organic light-emitting device is high, and the service life is long.

INHIBITORS OF FATTY ACID AMIDE HYDROLASE

The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). The present invention also provides methods for treating FAAH mediated disease, disorder or condition by administering a ther

2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

The present invention provides 2-furancarboxylic acid hydrazide compounds represented by General Formula(I) below, and prodrugs, physiologically acceptable salts, hydrates, solvates thereof, methods for producing them and pharmaceutical compositions containing them: wherein A is a group represented by Formula (a) or the like: (wherein either R4 or R5 represents cyano, nitro or the like, and the other represents a hydrogen atom or the like); either R1 or R2 represents a group: -D-(X)m-R6 or the like, and the other represents a group: -E-(Y)n-R7, hydrogen atom, aryl or the like; R3 is a hydrogen atom or the like; D and E independently represent aryl; X and Y independently represent 0 or the like; R6 and R7 independently represent alkyl, aryl, arylalkyl or the like; and m and n are independently 0 or 1, provided that the aryl is optionally substituted. Such compounds exhibit a potent antagonistic activity on glucagon receptor and are of use as preventive and/or therapeutic agents for symptoms and diseases in which glucagon is involved.